Nutranomics, Inc. (OTCBB:NNRX) Still Going Strong
After a bad end of October for Nutranomics, Inc. (OTCBB:NNRX), the stock started November more optimistically. The general direction of the stock’s price since the beginning of the month is upward and NNRX are working hard to ensure that it stays that way.
With no new paid promotions, NNRX are constantly touting their own stock with optimistic press releases and for now it seems to be working. With only 3 red sessions since the beginning of the month the total gain in price since the beginning of the month for NNRX is estimated at 119%.
And despite the high volumes of stock that were traded in yesterday’s session the ticker continued its ascent. After NNRX gapped up and opened at $0.799 per share there was a flurry of shares flying around, but that didn’t manage to bring the ticker down.
Instead of going down, pushed by the trading, however, the company stock managed to close even higher, registering a total gain of 12.84% in value, priced at $0.835. The amount of shares that switched hands was higher than the previous day’s, with 2.8 million that helped generate $2.2 million in dollar volume.
There are constant optimistic press releases coming from the company. Yesterday they announced that the current CEO, Dr. Tracy K. Gibbs is scheduled to begin and extendet strategic marketing and business tour of Asia, promoting the company’s products.
Today, NNRX announced the official commercial launch of GlucozymeTM, their nutritional supplement which assists the reduction of blood glucoze levels in patients with Type 2 diabetes.
Despite that, the company stock gapped down today and opened the session with a price of $0.824 per share and and it’s still sliding down, currently valued at $0.79. The volume for the moment remains high and there is still a lot of trading going on, but things might turn around when the trading quiets down.
In any case, be sure to do a lot of due diligence and weigh out the risks, because we must not forget that the company is yet to prove itself as profitable.
Growlife, Inc. (OTCBB:PHOT) also did good yesterday, as their stock gained a fair 29% on high volume that generated $3.48 million in dollar volume. Life Stem Genetics, Inc. (OTCBB:LIFS) didn’t fare so well and dropped 22% in value after a long period of ascending the charts.
